Home›Stock Screener›Onyx Biotec

Onyx Biotec Share Price Today | Stock Price & Onyx Biotec Share Screener

ONYX Pharmaceuticals & Biotechnology

Track the current Onyx Biotec share price and stock price live with TickJournal's free stock screener. Track Onyx Biotec market worth to gauge the company's total market size. Use the Onyx Biotec stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Onyx Biotec opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Onyx Biotec Market Cap ₹68.18 Cr.
ONYX P/E Ratio (TTM) -
Onyx Biotec P/B Ratio 1.29
EPS (TTM) ₹-0.12
Dividend Yield -
Debt to Equity 0.25
ONYX 52 Week High -
Onyx Biotec 52 Week Low -
Operating Margin -
Profit Margin -
ONYX Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹95.00
Total Equity ₹55.00

Onyx Biotec Share Price Chart

Track the current stock price of Onyx Biotec with an interactive chart. Analyse ONYX share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Onyx Biotec stock quote in one place.

Onyx Biotec Company Profile - Fundamental Screener

Screen Onyx Biotec company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ONYX shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE0WVU01018.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE0WVU01018

Onyx Biotec Balance Sheet Screener

Screen ONYX balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹95, up from ₹91 in 2025.

Latest statistics put total assets at ₹95 and shareholder funds at ₹55, with a leverage ratio of 0.25.

Item 2026 2025 2024 2023 2022

Assets

Total Assets 95 91 74 59 37
Current Assets 0 0 0 0 0
Fixed Assets 39 41 44 43 17

Liabilities

Total Liabilities 0 0 0 0 0
Current Liabilities 7 10 26 20 10
Non-Current Liabilities 0 0 0 0 0

Shareholders' Equity

Total Equity 55 56 25 18 16
Share Capital 18 18 13 6 6
Reserves & Surplus 37 38 12 12 11

Onyx Biotec Income Statement Screener - Profit & Revenue Analysis

Screen Onyx Biotec income statement and profit fundamentals. Analyze ONYX quarterly results. Onyx Biotec reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹70 and net profit of ₹0.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March

Revenue and Expenses

Revenue 0 70 63 54 40 45
Expenses 0 66 52 45 35 39

Operating Costs and Margins

EBITDA 0 4 12 9 5 6
Operating Profit % 0.00% 5.00% 17.00% 16.00% 11.00% 13.00%
Depreciation 0 3 3 2 2 1
Interest 0 1 2 2 1 1

Profit and Earnings

Profit Before Tax 0 0 7 5 3 4
Tax 0 0 2 1 1 0
Net Profit 0 0 5 4 2 3
EPS 0.00 -0.12 3.31 3.05 1.56 2.84

Onyx Biotec Cash Flow Screener - Liquidity Fundamentals

Screen ONYX cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹2, and net cash flow was an outflow of ₹5.

Over the same period, investing activities used ₹5 and financing activities provided ₹2.

Item 2026-March 2025-March 2024-March 2023-March 2022-March

Cash from Operations and Investing

Operating Activities -2 1 2 2 1
Investing Activities -5 1 -3 -23 -6

Financing and Net Cash

Financing Activities 2 5 3 16 5
Net Cash Flow -5 7 2 -4 0

Onyx Biotec Shareholding Pattern Screener

See Onyx Biotec shareholding pattern with promoter, FII, and DII holdings. Check Onyx Biotec promoter holding and ownership changes for ONYX on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 65.10%, foreign institutions 1.07%, domestic institutions 2.39% and the public 23.15%, spread across 586 shareholders.

The shareholder count was 586 in 2026-Mar, compared with 631 in 2026-Sept.

Item 2026-Mar 2026-Sept 2025-Mar 2025-Sept 2024-Nov

Promoter Holding

Promoter Holding 65.10% 41.74% 65.10% 65.10% 65.10%

Institutional Investors

FII Holding 1.07% 0.22% 0.00% 0.00% 0.00%
DII Holding 2.39% 2.39% 0.00% 0.00% 0.03%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 23.15% 50.96% 18.97% 22.64% 18.96%
Other Holding 8.29% 4.68% 15.94% 12.27% 15.92%
Shareholder Count 586 631 551 640 1,181

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Onyx Biotec. Onyx Biotec dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Onyx Biotec.

Onyx Biotec Stock Index Membership - Nifty & Sensex

See which indices include Onyx Biotec stock. Check ONYX index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Onyx Biotec is not part of any tracked indices.
Only major market indices are tracked in our system.

Onyx Biotec Market Events Screener - Corporate Actions

Get Onyx Biotec corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Onyx Biotec stock events that may affect ONYX share price, along with derivatives, futures and options activity and sector gainers.

5 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 14, 2026, with a record date of November 14, 2026.

It is followed by Quarterly Result Announcement dated May 14, 2026 and Quarterly Result Announcement dated November 13, 2025.

Announcement Date Record Date Event Type Information Price Impact
2026-11-14 2026-11-14 Quarterly Result Announcement NA 8.61%
2026-05-14 2026-05-14 Quarterly Result Announcement NA -4.90%
2025-11-13 2025-11-13 Quarterly Result Announcement NA 9.74%
2025-05-28 2025-05-28 Quarterly Result Announcement NA 1.32%
2025-01-10 2025-01-10 Quarterly Result Announcement NA -12.42%

Onyx Biotec Competitors Screener - Peer Stocks Comparison

Screen ONYX competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 449,036 40.80 61,674 12.69% 11,565 60.77
Divis Laboratories 293,316 87.70 11,067 13.95% 2,568 65.94
Torrent Pharmaceuticals 175,376 84.70 13,886 20.34% 2,138 42.26
Laurus Labs 125,488 94.90 6,868 22.01% 890 55.82
Zydus Life Science 119,900 27.90 27,658 17.64% 5,026 55.22
Dr Reddys Laboratories 116,705 42.00 35,059 3.90% 4,158 73.09
Cipla 114,474 39.20 29,045 2.24% 3,870 62.07
Mankind Pharma 108,424 47.50 14,636 14.85% 1,938 62.66
Aurobindo Pharma 103,355 25.90 34,145 5.56% 3,503 60.69
Lupin 90,173 17.10 29,039 26.75% 5,356 44.73

Onyx Biotec Company Announcements - News & Reports Screener

Screen ONYX latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

No company announcements available.

Frequently Asked Questions

How is the company valued right now?

The P/B ratio is 1.29. Market capitalisation stands at ₹68.18 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on November 21, 2026. This page covers 5 balance sheet periods, 6 income statement periods, 5 cash flow years and 5 shareholding periods. Information is provided for research and is not investment advice.